ArticleJournal of blood medicine2019

Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date.

Tanya R Riley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.